Found: 104
Select item for more details and to access through your institution.
A prognostic algorithm including a modified version of MD Anderson Cancer Center (MDACC) score predicts time to first treatment of patients with clinical monoclonal lymphocytosis (cMBL)/Rai stage 0 chronic lymphocytic leukemia (CLL).
- Published in:
- International Journal of Hematology, 2014, v. 100, n. 3, p. 290, doi. 10.1007/s12185-014-1634-7
- By:
- Publication type:
- Article
Prognostic relevance of serum levels and cellular expression of adiponectin in B-cell chronic lymphocytic leukemia.
- Published in:
- 2008
- By:
- Publication type:
- journal article
Venetoclax-Rituximab Treatment of Relapsed/Refractory CLL During the COVID-19 Pandemic: A Real-Life Experience in Selected Central-Southern Italian Regions.
- Published in:
- Mediterranean Journal of Hematology & Infectious Diseases, 2021, v. 13, n. 1, p. 1, doi. 10.4084/MJHID.2021.042
- By:
- Publication type:
- Article
Prognostic value of the lymphocyte doubling time in chronic lymphocytic leukemia.
- Published in:
- 1987
- By:
- Publication type:
- journal article
International validation of the EORTC QLQ‐CLL17 questionnaire for assessment of health‐related quality of life for patients with chronic lymphocytic leukaemia.
- Published in:
- British Journal of Haematology, 2022, v. 197, n. 4, p. 431, doi. 10.1111/bjh.18072
- By:
- Publication type:
- Article
Serum levels of soluble calreticulin predict for time to first treatment in early chronic lymphocytic leukaemia.
- Published in:
- British Journal of Haematology, 2016, v. 175, n. 5, p. 983, doi. 10.1111/bjh.13907
- By:
- Publication type:
- Article
Is ZAP70 still a key prognostic factor in early stage chronic lymphocytic leukaemia? Results of the analysis from a prospective multicentre observational study.
- Published in:
- British Journal of Haematology, 2015, v. 168, n. 3, p. 455, doi. 10.1111/bjh.13117
- By:
- Publication type:
- Article
High-throughput sequencing for the identification of NOTCH1 mutations in early stage chronic lymphocytic leukaemia: biological and clinical implications.
- Published in:
- British Journal of Haematology, 2014, v. 165, n. 5, p. 629, doi. 10.1111/bjh.12800
- By:
- Publication type:
- Article
Network meta‐analysis of upfront fixed‐duration therapies in chronic lymphocytic leukemia.
- Published in:
- American Journal of Hematology, 2024, v. 99, n. 10, p. 2041, doi. 10.1002/ajh.27437
- By:
- Publication type:
- Article
Impact of targeted agents on survival of chronic lymphocytic leukemia patients age >65 relative to age‐ and sex‐matched population.
- Published in:
- American Journal of Hematology, 2024, v. 99, n. 3, p. 480, doi. 10.1002/ajh.27182
- By:
- Publication type:
- Article
Prediction of outcomes in chronic lymphocytic leukemia patients treated with ibrutinib: Validation of current prognostic models and development of a simplified three‐factor model.
- Published in:
- American Journal of Hematology, 2022, v. 97, n. 5, p. E176, doi. 10.1002/ajh.26502
- By:
- Publication type:
- Article
Continuous treatment with Ibrutinib in 100 untreated patients with TP53 disrupted chronic lymphocytic leukemia: A real‐life campus CLL study.
- Published in:
- American Journal of Hematology, 2022, v. 97, n. 3, p. E95, doi. 10.1002/ajh.26437
- By:
- Publication type:
- Article
Flow Cytometric Immunobead Assay for Detection of BCR-ABL1 Fusion Proteins in Chronic Myleoid Leukemia: Comparison with FISH and PCR Techniques.
- Published in:
- PLoS ONE, 2015, v. 10, n. 6, p. 1, doi. 10.1371/journal.pone.0130360
- By:
- Publication type:
- Article
Relevance of Stereotyped B-Cell Receptors in the Context of the Molecular, Cytogenetic and Clinical Features of Chronic Lymphocytic Leukemia.
- Published in:
- PLoS ONE, 2011, v. 6, n. 8, p. 1, doi. 10.1371/journal.pone.0024313
- By:
- Publication type:
- Article
Chronic lymphocytic leukemia international prognostic index (CLL-IPI) in patients receiving chemoimmuno or targeted therapy: a systematic review and meta-analysis.
- Published in:
- 2018
- By:
- Publication type:
- Letter
Visceral leishmaniasis infection in a refractory multiple myeloma patient treated with bortezomib.
- Published in:
- 2012
- By:
- Publication type:
- Letter
Ibrutinib continues to influence the therapeutic landscape of chronic lymphocytic leukemia: new data presented at ASCO 2017.
- Published in:
- 2017
- By:
- Publication type:
- journal article
Spotlight on landmark oncology trials: the latest evidence and novel trial designs.
- Published in:
- 2017
- By:
- Publication type:
- Editorial
Impact of Targeted Agents on Survival of Chronic Lymphocytic Leukemia Patients Fit for Fludarabine, Cyclophosphamide, and Rituximab (FCR) Relative to Age- and Sex-Matched Population.
- Published in:
- Cancers, 2024, v. 16, n. 6, p. 1085, doi. 10.3390/cancers16061085
- By:
- Publication type:
- Article
Venetoclax: A Game Changer in the Treatment of Younger AML Patients?
- Published in:
- Cancers, 2024, v. 16, n. 1, p. 73, doi. 10.3390/cancers16010073
- By:
- Publication type:
- Article
Advancements in the Treatment of CLL: The Rise of Zanubrutinib as a Preferred Therapeutic Option.
- Published in:
- Cancers, 2023, v. 15, n. 14, p. 3737, doi. 10.3390/cancers15143737
- By:
- Publication type:
- Article
Efficacy of Front-Line Ibrutinib and Rituximab Combination and the Impact of Treatment Discontinuation in Unfit Patients with Chronic Lymphocytic Leukemia: Results of the Gimema LLC1114 Study.
- Published in:
- Cancers, 2022, v. 14, n. 1, p. 207, doi. 10.3390/cancers14010207
- By:
- Publication type:
- Article
Current Treatment Options in CLL.
- Published in:
- Cancers, 2021, v. 13, n. 10, p. 2468, doi. 10.3390/cancers13102468
- By:
- Publication type:
- Article
Elevated Lactate Dehydrogenase Has Prognostic Relevance in Treatment-Naïve Patients Affected by Chronic Lymphocytic Leukemia with Trisomy 12.
- Published in:
- Cancers, 2019, v. 11, n. 7, p. 896, doi. 10.3390/cancers11070896
- By:
- Publication type:
- Article
The net clinical benefit of targeted agents in the upfront treatment of elderly/unfit chronic lymphocytic leukemia patients: Results of network meta‐analysis.
- Published in:
- European Journal of Haematology, 2023, v. 110, n. 6, p. 774, doi. 10.1111/ejh.13943
- By:
- Publication type:
- Article
mRNA COVID‐19 vaccines in patients with chronic lymphocytic leukemia: A systematic review and meta‐analysis.
- Published in:
- European Journal of Haematology, 2022, v. 108, n. 3, p. 264, doi. 10.1111/ejh.13729
- By:
- Publication type:
- Article
Prognostic models in chronic lymphocytic leukemia patients receiving ibrutinib therapy: Results of a comparative performance analysis.
- Published in:
- European Journal of Haematology, 2021, v. 106, n. 3, p. 425, doi. 10.1111/ejh.13548
- By:
- Publication type:
- Article
Ibrutinib as initial therapy in chronic lymphocytic leukemia: A systematic review and meta‐analysis.
- Published in:
- European Journal of Haematology, 2020, v. 104, n. 5, p. 512, doi. 10.1111/ejh.13387
- By:
- Publication type:
- Article
Response-Guided ABVD Chemotherapy plus Involved-Field Radiation Therapy for Intermediate-Stage Hodgkin Lymphoma in the Pre–Positron Emission Tomography Era: A Gruppo Italiano Studio Linfomi (GISL) Prospective Trial.
- Published in:
- Clinical Lymphoma & Myeloma, 2009, v. 9, n. 2, p. 138
- By:
- Publication type:
- Article
TH2/TH1 Shift Under Ibrutinib Treatment in Chronic Lymphocytic Leukemia.
- Published in:
- Frontiers in Oncology, 2021, v. 11, p. N.PAG, doi. 10.3389/fonc.2021.637186
- By:
- Publication type:
- Article
Tolerability and efficacy of busulfan and fludarabine as allogeneic pretransplant conditioning therapy in acute myeloid leukemia: comparison with busulfan and cyclophosphamide regimen.
- Published in:
- 2014
- By:
- Publication type:
- Journal Article
Long-term results in multiple myeloma after high-dose melphalan and autologous transplantation according to response categories in the era of old drugs.
- Published in:
- 2014
- By:
- Publication type:
- Journal Article
Does Adiponectin Act as an Antiangiogenic Factor in B-Cell Chronic Lymphocytic Leukemia?
- Published in:
- Advances in Hematology, 2009, v. 2009, p. 1, doi. 10.1155/2009/287974
- By:
- Publication type:
- Article
Predictive value of the CLL‐IPI in CLL patients receiving chemo‐immunotherapy as first‐line treatment.
- Published in:
- European Journal of Haematology, 2018, v. 101, n. 5, p. 703, doi. 10.1111/ejh.13149
- By:
- Publication type:
- Article
Prospective validation of predictive value of abdominal computed tomography scan on time tofirst treatment in Rai 0 chronic lymphocytic leukemia patients: results of the multicenter O-CLL1-GISL study.
- Published in:
- European Journal of Haematology, 2016, v. 96, n. 1, p. 36, doi. 10.1111/ejh.12545
- By:
- Publication type:
- Article
Unavailability of thymidine kinase does not preclude the use of German comprehensive prognostic index: results of an external validation analysis in early chronic lymphocytic leukemia and comparison with MD Anderson Cancer Center model.
- Published in:
- European Journal of Haematology, 2016, v. 96, n. 1, p. 72, doi. 10.1111/ejh.12550
- By:
- Publication type:
- Article
Progressive peripheral arterial occlusive disease and other vascular events during nilotinib therapy in chronic myeloid leukemia: a single institution study.
- Published in:
- European Journal of Haematology, 2013, v. 90, n. 6, p. 531, doi. 10.1111/ejh.12096
- By:
- Publication type:
- Article
Baff serum level predicts time to first treatment in early chronic lymphocytic leukemia.
- Published in:
- European Journal of Haematology, 2010, v. 85, n. 4, p. 314, doi. 10.1111/j.1600-0609.2010.01482.x
- By:
- Publication type:
- Article
Serum level of CD26 predicts time to first treatment in early B-chronic lymphocytic leukemia.
- Published in:
- European Journal of Haematology, 2009, v. 83, n. 3, p. 208, doi. 10.1111/j.1600-0609.2009.01273.x
- By:
- Publication type:
- Article
Serum insulin-like growth factor is not elevated in patients with early B-cell chronic lymphocytic leukemia but is still a prognostic factor for disease progression.
- Published in:
- European Journal of Haematology, 2006, v. 76, n. 1, p. 51, doi. 10.1111/j.1600-0609.2005.00553.x
- By:
- Publication type:
- Article
Serum angiogenin is not elevated in patients with early B-cell chronic lymphocytic leukemia but is prognostic factor for disease progression.
- Published in:
- European Journal of Haematology, 2004, v. 73, n. 1, p. 36, doi. 10.1111/j.1600-0609.2004.00269.x
- By:
- Publication type:
- Article
Tryptase-positive mast cells predict clinical outcome of patients with early B-cell chronic lymphocytic leukemia.
- Published in:
- European Journal of Haematology, 2003, v. 71, n. 2, p. 137, doi. 10.1034/j.1600-0609.2003.00110.x
- By:
- Publication type:
- Article
Increased serum levels of matrix metalloproteinase-9 predict clinical outcome of patients with early B-cell chronic lymphocytic leukaemia.
- Published in:
- European Journal of Haematology, 2003, v. 70, n. 6, p. 373, doi. 10.1034/j.1600-0609.2003.00064.x
- By:
- Publication type:
- Article
Clinico-prognostic implications of simultaneous increased serum levels of soluble CD23 and β<sub>2</sub>-microglobulin in B-cell chronic lymphocytic leukemia.
- Published in:
- European Journal of Haematology, 1999, v. 62, n. 2, p. 117, doi. 10.1111/j.1600-0609.1999.tb01731.x
- By:
- Publication type:
- Article
Vinblastine, bleomycin, and methotrexate chemotherapy plus irradiation for patients with early-stage, favorable Hodgkin lymphoma.
- Published in:
- Cancer (0008543X), 2003, v. 98, n. 11, p. 2393
- By:
- Publication type:
- Article
Elevated serum levels of soluble CD44 can identify a subgroup of patients with early B-cell chronic lymphocytic leukemia who are at high risk of disease progression.
- Published in:
- 2001
- By:
- Publication type:
- journal article
Spectrum of β-thalassemia mutations in Calabria: Implications for prenatal diagnosis.
- Published in:
- American Journal of Hematology, 1995, v. 48, n. 2, p. 128, doi. 10.1002/ajh.2830480213
- By:
- Publication type:
- Article
High-dose dexamethasone in refractory B-cell chronic lymphocytic leukemia patients.
- Published in:
- American Journal of Hematology, 1994, v. 47, n. 4, p. 334, doi. 10.1002/ajh.2830470421
- By:
- Publication type:
- Article
Combined use of α<sub>2B</sub>-interferon, chlorambucil, and prednisone in the treatment of previously treated B-chronic lymphocytic leukemia patients.
- Published in:
- American Journal of Hematology, 1993, v. 42, n. 3, p. 334, doi. 10.1002/ajh.2830420316
- By:
- Publication type:
- Article
Myelomonocytic associated antigens in early B-chronic lymphocytic leukemia correlate with disease activity.
- Published in:
- American Journal of Hematology, 1992, v. 40, n. 4, p. 319, doi. 10.1002/ajh.2830400418
- By:
- Publication type:
- Article